 Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
| Descriptor ID |
D004359
|
| MeSH Number(s) |
E02.319.310
|
| Concept/Terms |
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 7 | 7 | | 1996 | 0 | 6 | 6 | | 1997 | 0 | 8 | 8 | | 1998 | 0 | 13 | 13 | | 1999 | 0 | 11 | 11 | | 2000 | 0 | 14 | 14 | | 2001 | 1 | 15 | 16 | | 2002 | 1 | 10 | 11 | | 2003 | 1 | 14 | 15 | | 2004 | 0 | 29 | 29 | | 2005 | 1 | 25 | 26 | | 2006 | 0 | 26 | 26 | | 2007 | 0 | 19 | 19 | | 2008 | 0 | 20 | 20 | | 2009 | 0 | 18 | 18 | | 2010 | 0 | 25 | 25 | | 2011 | 0 | 36 | 36 | | 2012 | 0 | 37 | 37 | | 2013 | 3 | 25 | 28 | | 2014 | 0 | 38 | 38 | | 2015 | 0 | 52 | 52 | | 2016 | 1 | 42 | 43 | | 2017 | 2 | 48 | 50 | | 2018 | 1 | 38 | 39 | | 2019 | 0 | 39 | 39 | | 2020 | 0 | 41 | 41 | | 2021 | 0 | 34 | 34 | | 2022 | 0 | 14 | 14 | | 2023 | 0 | 13 | 13 | | 2024 | 3 | 15 | 18 | | 2025 | 0 | 13 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Almond CS, Daly KP, Albers EL, Alejos JC, Ameduri R, Auerbach SR, Barkoff L, Barnes AP, Bock MJ, Butto A, Carlo WF, Castleberry CD, Chrisant MR, Deshpande SR, Dreyer WJ, Everitt MD, Feingold B, Gonzales S, Hollander SA, Kindel SJ, Klein GL, Lal AK, Lamour JM, Lee J, Lu M, Lytrivi ID, Miyamoto SD, Pahl E, Peng DM, Ryan TD, Singh TP, Su JA, Sutcliffe DL, Ybarra AM, Zangwill S, Rossano JW, Sleeper LA. Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children: A Randomized Clinical Trial. JAMA. 2025 Oct 21; 334(15):1339-1348.
-
Verheye S, Ferdinande B, Bennett J, Staico R, El-Jack S, Tonino PAL, Abizaid A, Buysschaert I, Scott D, Menon M, Wilkins G, McClean D, Kovarnik T, Christians U, Neylon A, Mehmedbegovic Z, Smits PC, Morice MC, Webster M. Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus. Catheter Cardiovasc Interv. 2025 Oct; 106(4):2770-2780.
-
Shimamura A, Maschan A, Bennett C, Samarasinghe S, Farrar JE, Li CK, Sirachainan N, Pongtanakul B, Komvilaisak P, Zubarovskaya L, Rothman JA, Walkovich K, Nakano TA, Bertuch AA, Ferrao A, Bhat R, Hanna R, Overholt K, Boklan J, Wong TF, Wang Q, Urban P, Strahm B, Wang W, Vlachos A, Williams DA. Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial. Blood Adv. 2025 Aug 12; 9(15):3728-3738.
-
Pour-Rashidi A, Zandpazandi S, Hsu S, Shakeri A, Safari N, Apuzzo M, Stieg PE. Comparative analysis of monotherapy versus duotherapy with antiseizure medications for intraoperative and early postoperative seizure control in glioma patients undergoing awake craniotomy. J Neurooncol. 2025 Oct; 175(1):303-312.
-
Batt CE, Puccio OC, Kelsey MM, Boles RE, Moore JM. Real-World Use of Phentermine and Topiramate for Adolescent Obesity: Retrospective Effectiveness and Safety Analysis. Child Obes. 2025 Oct; 21(7):580-588.
-
Rayner DG, Bakaa L, Hoyte F, Perry TT, Rivera-Spoljaric K, Sumino K, Chipps B, Oppenheimer J, Nyenhuis SM, Israel E, McCabe E, O'Byrne PM, Shade LE, Press VG, Guyatt GH, Rangel S, Sue-Wah-Sing D, Hall L, Orr H, Melendez A, Winders T, Gardner DD, Przywara K, Rank MA, Bacharier LB, Mosnaim G, Chu DK. Triple therapy vs dual inhaler therapy for moderate-to-severe asthma: An updated systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2025 Sep; 135(3):278-286.e11.
-
van Baar MJB, Muskiet MHA, Scholtes RA, Touw DJ, Nieuwdorp M, Kramer MHH, Joles JA, Cherney DZI, Bjornstad P, Krebber MM, van Raalte DH. Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono- and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double-blind trial. Diabetes Obes Metab. 2025 Jul; 27(7):3943-3956.
-
Humbert M, McLaughlin VV, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Preston IR, Souza R, Waxman AB, Moles VM, Savale L, Vizza CD, Rosenkranz S, Shi Y, Miller B, Mackenzie HS, Kim SS, Loureiro MJ, Patel MJ, Koglin J, Cornell AG, Hoeper MM. Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death. N Engl J Med. 2025 May 29; 392(20):1987-2000.
-
Kaur P, Chaisson LH, Kiragu ZW, Buddadhumaruk P, Austin AF, Gao Y, Wirtz VJ, Arbeit RD, Fetalvero KB, Nguyen HB, Nguyen NV, Ha H, Eisenach K, Walter ND, Mitnick CD, Gler MTS, Phan H, Nahid P, Phillips PPJ, Horsburgh CR, Velásquez GE. Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The DRAMATIC trial. Contemp Clin Trials. 2025 May; 152:107875.
-
Beck RW, Bailey RJ, Akturk HK, Rizvi S, Kudva Y, Blevins T, Church MM, Manessis A, Calhoun P, Ruedy KJ, Hirsch IB. A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes. Diabetes Technol Ther. 2025 Mar; 27(3):161-169.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|